Clinical Trial Update: Extension Study to Compare Long-term Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With RVO [Phase 4]

View source ↗

Summary

Phase 4 extension trial comparing long-term efficacy and safety of ranibizumab intravitreal injections versus the dexamethasone intravitreal implant in retinal …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinal Vein Occlusion

Drugs mentioned

• Lucentis (ranibizumab)
• Ozurdex (dexamethasone intravitreal implant)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Retinal Vein Occlusion | Phase 4 | Status: COMPLETED | Results posted: 2016-05-17